Walgreens stands up for the value of pharmacy
With the end of the year less than three weeks away, it appears all but certain that Walgreens will not be part of Express Scripts’ network of pharmacy providers when 2012 gets under way.
Latest
Watson introduces Amethia Lo
Watson Pharmaceuticals Inc. is rolling out Amethia Lo tablets, an oral contraceptive. Watson said late Wednesday that it has launched Amethia Lo (levonorgestrel/ethinyl estradiol 0.1 mg/0.02 mg) and ethinyl estradiol (0.01 mg) tablets under a settlement with Teva Women’s Health Inc.
GPhA names VP of policy and alliances
The Generic Pharmaceutical Association (GPhA) has hired Ahaviah Glaser as vice president for policy and strategic alliances.
HDMA recognizes senator for Rx safety
The Healthcare Distribution Management Association (HDMA) has honored Sen. Pat Roberts (R., Kan.) with its Rx Safety and Healthcare Leadership Award.
London Drugs photo site integrates social media
London Drugs has launched a new Photolab website that enables customers to log into and access images from Facebook, Flickr, Google+ and Picasa social media accounts and create a variety of photo products.
Walgreens to PBM: Let’s make a Tricare deal
Walgreen Co. said more than 250,000 beneficiaries in the military’s Tricare health plan have petitioned Express Scripts Inc. to keep the drug chain in its pharmacy provider network.
AstraZeneca to downsize U.S. sales force
AstraZeneca plans to cut more than 1,000 jobs from its U.S. sales force as part of a restructuring program unveiled last year. The pharmaceutical firm said Wednesday that it aims to eliminate about 1,150 leadership positions and sales representatives, or roughly 24% of its U.S. sales organization.
Bill seeks tougher penalties for counterfeit drug traffickers
The National Association of Chain Drug Stores has endorsed legislation that aims to stiffen penalties on criminals engaged in trafficking counterfeit medications. NACDS said Wednesday that it has sent a letter of support to Sen. Patrick Leahy (D., Vt.
HHS nixes FDA OK of wider OTC use for morning-after pill
U.S. Department of Health and Human Services Secretary Kathleen Sebelius has overruled a decision by the Food and Drug Administration that would have allowed women under age 17 to buy the Plan B One-Step morning-after pill without a prescription.
CVS ramps up mobile shopping platform
Catering to the swelling ranks of smartphone users, CVS/pharmacy has made the entire CVS.com catalog available to shoppers through its mobile site (m.cvs.com). CVS said Wednesday that the move, which also includes access to the CVS Photo mobile site (m.cvsphoto.com) and MinuteClinic mobile site (m.
Ranbaxy rolls out Caduet authorized generic
Ranbaxy Pharmaceuticals Inc. has launched an authorized generic version of Caduet, indicated for the treatment of high blood pressure and high cholesterol. Ranbaxy said Tuesday that the product is being introduced in the U.S. market under an agreement with Pfizer Inc.
CEO succession, new COO at Prasco
Christopher Arington has been promoted to vice chairman and chief executive officer of authorized generic drug maker Prasco Laboratories. Previously president and chief operating officer, he takes the CEO reins from his father, Prasco chairman and founder E. Thomas Arington.
Senate PBM hearing: Retail Rx execs blast merger
Retail pharmacy executives told a Senate panel that the merger of Express Scripts Inc. and Medco Health Solutions Inc., if approved, could lead to higher prescription drug costs and limit patient access to pharmacy services, in turn negatively impacting health outcomes.
Consumers satisfied with Rx coverage, survey says
When it comes to prescription drug benefits, cost matters much more to consumers than access to every branded medication and local drug store, according to a survey commissioned by the Pharmaceutical Care Management Association (PCMA).
Helen of Troy to acquire PUR from P&G
Helen of Troy Ltd. plans to buy the PUR water filtration product business from Procter & Gamble Co.
Horizon releases Duexis in U.S.
Horizon Pharma Inc. has launched Duexis, a proprietary single-tablet combination of ibuprofen (800 mg) and famotidine (26.6 mg), in the United States.